The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
Open accessAbstract
BACKGROUND: Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization. METHODS: We conducted a randomized, double-blind trial comparing a sirolimus-eluting stent with a standard stent in 1058 patients at 53 centers in the United States who had a newly diagnosed lesion in a native coronary artery. The coronary disease in these patients was complex because of the frequent presence of diabetes (in 26 percent of patients), the high percentage of patients with longer lesions (mean, 14.4 mm), and small vessels (mean, 2.80 mm). The primary end point was failure of the target vessel (a composite of death from cardiac causes, myocardial infarction, and repeated percutaneous or surgical revascularization of the target vessel) within 270 days. RESULTS: The rate of failure of the target vessel was reduced from 21.0 percent with a standard stent to 8.6 percent with a sirolimus-eluting stent (P<0.001)--a reduction that was driven largely by a decrease in the frequency of the need for revascularization of the target lesion (16.6 percent in the standard-stent group vs. 4.1 percent in the sirolimus-stent group, P<0.001). The frequency of neointimal hyperplasia within the stent was also decreased in the group that received sirolimus-eluting stents, as assessed by both angiography and intravascular ultrasonography. Subgroup analyses revealed a reduction in the rates of angiographic restenosis and target-lesion revascularization in all subgroups examined. CONCLUSIONS: In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310802 · Cited by 4,271
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F., & Kappenberger, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161201 · Cited by 1,892
Angiographic Patterns of In-Stent Restenosis: Classification and Implications for Long-Term Outcome
Mehran, R., Dangas, G., Abizaid, A. S., Mintz, G. S., Lansky, A. J., Satler, L. F., Pichard, A. D., Kent, K. M., Stone, G. W., & Leon, M. B. (1999) · Circulation · doi:10.1161/01.cir.100.18.1872 · Cited by 1,258
Self-citationSousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.192 · Cited by 793
Self-citationStent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
Suzuki, T., Kopia, G., Hayashi, S.-I., Bailey, L. R., Llanos, G., Wilensky, R., Klugherz, B. D., Papandreou, G., Narayan, P., Leon, M. B., et al. (2001) · Circulation · doi:10.1161/hc3601.093987 · Cited by 708
Self-citationSousa, J. E., Costa, M. A., Abizaid, A. C., Rensing, B. J., Abizaid, A. S., Tanajura, L. F., Kozuma, K., Van Langenhove, G., Sousa, A. G. M. R., Falotico, R., et al. (2001) · Circulation · doi:10.1161/hc4201.098056 · Cited by 672
Self-citationRoubin, G. S., Cannon, A. D., Agrawal, S. K., Macander, P. J., Dean, L. S., Baxley, W. A., & Breland, J. (1992) · Circulation · doi:10.1161/01.cir.85.3.916 · Cited by 582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
Kimura, T., Yokoi, H., Nakagawa, Y., Tamura, T., Kaburagi, S., Sawada, Y., Sato, Y., Yokoi, H., Hamasaki, N., Nosaka, H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340903 · Cited by 507
Cited by
Items 101–141 of 141
Palmerini, T., Biondi-Zoccai, G., Della Riva, D., Mariani, A., Sabaté, M., Smits, P. C., Kaiser, C., D'Ascenzo, F., Frati, G., Mancone, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.061 · Cited by 313
Kastrati, A., Dibra, A., Mehilli, J., Mayer, S., Pinieck, S., Pache, J., Dirschinger, J., & Schömig, A. (2006) · Circulation · doi:10.1161/circulationaha.105.601823 · Cited by 312
Current Status of Rotational Atherectomy
Tomey, M. I., Kini, A. S., & Sharma, S. K. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.12.196 · Cited by 312
Bangalore, S., Toklu, B., Amoroso, N., Fusaro, M., Kumar, S., Hannan, E. L., Faxon, D. P., & Feit, F. (2013) · BMJ · doi:10.1136/bmj.f6625 · Cited by 310
Chieffo, A., Morici, N., Maisano, F., Bonizzoni, E., Cosgrave, J., Montorfano, M., Airoldi, F., Carlino, M., Michev, I., Melzi, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.595694 · Cited by 310
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E. P., Merlini, F., Ansani, L., et al. (2005) · JAMA · doi:10.1001/jama.293.17.2109 · Cited by 307
Mehilli, J., Kastrati, A., Schühlen, H., Dibra, A., Dotzer, F., von Beckerath, N., Bollwein, H., Pache, J., Dirschinger, J., Berger, P. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148956.93631.4d · Cited by 303
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., & Ho, K. K. L. (2004) · Circulation · doi:10.1161/01.cir.0000140721.27004.4b · Cited by 302
Self-citationMacroscale delivery systems for molecular and cellular payloads
Kearney, C. J., & Mooney, D. J. (2013) · Nature Materials · doi:10.1038/nmat3758 · Cited by 301
Restenosis after PCI. Part 1: pathophysiology and risk factors
Jukema, J. W., Verschuren, J. J. W., Ahmed, T. A. N., & Quax, P. H. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.132 · Cited by 299
Nakazawa, G., Finn, A. V., Vorpahl, M., Ladich, E. R., Kolodgie, F. D., & Virmani, R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.066 · Cited by 299
JEWELL, C., & LYNN, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.010 · Cited by 297
Lu, J., Rao, M. P., MacDonald, N. C., Khang, D., & Webster, T. J. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.07.008 · Cited by 290
Wahl, P. R., Serra, A. L., Le Hir, M., Molle, K. D., Hall, M. N., & Wüthrich, R. P. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi181 · Cited by 287
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
Karjalainen, P. P., Porela, P., Ylitalo, A., Vikman, S., Nyman, K., Vaittinen, M.-A., Airaksinen, T. J., Niemela, M., Vahlberg, T., & Airaksinen, K. E. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl488 · Cited by 286
Lee, C. W., Ahn, J.-M., Park, D.-W., Kang, S.-J., Lee, S.-W., Kim, Y.-H., Park, S.-W., Han, S., Lee, S.-G., Seong, I.-W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003303 · Cited by 284
Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suárez de Lezo, J., Goy, J.-J., Ulm, K., & Schömig, A. (2005) · JAMA · doi:10.1001/jama.294.7.819 · Cited by 282
Habara, S., Mitsudo, K., Kadota, K., Goto, T., Fujii, S., Yamamoto, H., Katoh, H., Oka, N., Fuku, Y., Hosogi, S., et al. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.10.012 · Cited by 281
CARTER, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.029 · Cited by 281
Coronary Stent Restenosis in Patients Treated With Cilostazol
Douglas, J. S., Holmes, D. R., Kereiakes, D. J., Grines, C. L., Block, E., Ghazzal, Z. M. B., Morris, D. C., Liberman, H., Parker, K., Jurkovitz, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.530097 · Cited by 281
Self-citationDiabetes and Coronary Revascularization
Flaherty, J. D. (2005) · JAMA · doi:10.1001/jama.293.12.1501 · Cited by 278
Bosiers, M., Scheinert, D., Peeters, P., Torsello, G., Zeller, T., Deloose, K., Schmidt, A., Tessarek, J., Vinck, E., & Schwartz, L. B. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.099 · Cited by 277
Charytan, D., & Kuntz, R. E. (2006) · Kidney International · doi:10.1038/sj.ki.5001934 · Cited by 271
Self-citationOutcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
Beohar, N., Davidson, C. J., Kip, K. E., Goodreau, L., Vlachos, H. A., Meyers, S. N., Benzuly, K. H., Flaherty, J. D., Ricciardi, M. J., Bennett, C. L., et al. (2007) · JAMA · doi:10.1001/jama.297.18.1992 · Cited by 270
Self-citationA Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications
Marroquin, O. C., Selzer, F., Mulukutla, S. R., Williams, D. O., Vlachos, H. A., Wilensky, R. L., Tanguay, J.-F., Holper, E. M., Abbott, J. D., Lee, J. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706258 · Cited by 270
Self-citationKaul, S., & Diamond, G. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.065 · Cited by 269
Unanswered Questions — Drug-Eluting Stents and the Risk of Late Thrombosis
Maisel, W. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068305 · Cited by 268
Vermeersch, P., Agostoni, P., Verheye, S., Van den Heuvel, P., Convens, C., Van den Branden, F., & Van Langenhove, G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.010 · Cited by 264
Brener, S. J., Lytle, B. W., Casserly, I. P., Schneider, J. P., Topol, E. J., & Lauer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000126826.58526.14 · Cited by 264
Impact of the Everolimus-Eluting Stent on Stent Thrombosis
Baber, U., Mehran, R., Sharma, S. K., Brar, S., Yu, J., Suh, J.-W., Kim, H.-S., Park, S.-J., Kastrati, A., de Waha, A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.049 · Cited by 263
Jensen, L. O., Maeng, M., Kaltoft, A., Thayssen, P., Hansen, H. H. T., Bottcher, M., Lassen, J. F., Krussel, L. R., Rasmussen, K., Hansen, K. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.002 · Cited by 263
Curcio, A., Torella, D., & Indolfi, C. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0366 · Cited by 262
The multiple facets of mTOR in immunity
Weichhart, T., & Säemann, M. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.02.002 · Cited by 259
Pathological Findings at Bifurcation Lesions
Nakazawa, G., Yazdani, S. K., Finn, A. V., Vorpahl, M., Kolodgie, F. D., & Virmani, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.021 · Cited by 257
Vermeersch, P., Agostoni, P., Verheye, S., Van den Heuvel, P., Convens, C., Bruining, N., Van den Branden, F., & Van Langenhove, G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.021 · Cited by 256
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B., Lamm, D., O'Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 252
mTOR pathway as a target in tissue hypertrophy
Lee, C.-H., Inoki, K., & Guan, K.-L. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105359 · Cited by 179
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
Ribichini, F., Tomai, F., De Luca, G., Boccuzzi, G., Presbitero, P., Pesarini, G., Ferrero, V., Ghini, A. S., Abukaresh, R., Aurigemma, C., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.027 · Cited by 31
Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Metadata
- Authors
- Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., Jaeger, J. L., & Kuntz, R. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-02
- Volume
- 349
- Issue
- 14
- Pages
- 1315-1323
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083630382
- Cited by
- 4,224
- References
- 25
- FWCI
- 316.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.